| Literature DB >> 32120282 |
Joseph Maalouly1, Antonios Tawk2, Dany Aouad3, Hicham Abdel Nour4, Elias Saidy5, Ghadi Abboud6, Georges El Rassi7.
Abstract
OBJECTIVE: This study aims to investigate the presence of any differences between the normal population and patients with rotator cuff tears in term of glenoid morphological parameters.Entities:
Keywords: Arthroscopy; Biomechanics; Case series; Glenoid; Magnetic resonance images; Rotator cuff; Shoulder
Year: 2020 PMID: 32120282 PMCID: PMC7052435 DOI: 10.1016/j.ijscr.2020.02.035
Source DB: PubMed Journal: Int J Surg Case Rep ISSN: 2210-2612
Fig. 1Measurement of GVA on axial MRI.
Fig. 2Measurement of the GIA shoulder X-ray in the anteroposterior view. GIA is the angle in the superolateral quadrant.
Fig. 3Glenoid height in the coronal view on shoulder MRI.
Fig. 4Glenoid depth as seen on the coronal view on shoulder MRI.
Fig. 5Glenoid axial width and depth.
The distribution of descriptive characteristics (gender and age) of the patient and control groups.
| Groups | Patient group (n = 41) | Control group (n = 41) | Total | |
|---|---|---|---|---|
| Gender | 11 (27%) | 16 (39%) | 27 (33%) | |
| 30 (73%) | 25 (61%) | 55 (67%) | ||
| Age (years) | 46.54 ± 15.84 | 38.37 ± 13.69 | 42.45 ± 15.27 | |
| 19–73 | 17–76 | 17–76 | ||
The comparison of glenohumeral morphological parameters of two groups.
| Parameters | Group | Group Statistics | Levene's Test for Equality of Variances | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N | Mean | SD | Variances | F | P-value | t | P-value | ||
| GVA | Patient group | 41 | 2.18 | 8.54 | EVA | 0.355 | 0.553 | −1.996 | 0.049* |
| Control group | 41 | 5.85 | 8.11 | EVNA | −1.996 | 0.049 | |||
| GCH | Patient group | 41 | 3.05 | 0.42 | EVA | 6.144 | 0.015 | 1.780 | 0.079 |
| Control group | 41 | 2.91 | 0.30 | EVNA | 1.780 | 0.079 | |||
| GAW | Patient group | 41 | 2.97 | 0.30 | EVA | 2.117 | 0.150 | −2.974 | 0.004** |
| Control group | 41 | 3.19 | 0.37 | EVNA | −2.974 | 0.004** | |||
| GAD | Patient group | 41 | 0.38 | 0.09 | EVA | 2.187 | 0.143 | −3.285 | 0.002** |
| Control group | 41 | 0.45 | 0.11 | EVNA | −3.285 | 0.002** | |||
| GCD | Patient group | 41 | 0.42 | 0.08 | EVA | 1.652 | 0.202 | 5.980 | 0.000** |
| Control group | 41 | 0.32 | 0.07 | EVNA | 5.980 | 0.000** | |||
| GD | Patient group | 41 | 0.40 | 0.05 | EVA | 6.034 | 0.016 | 1.099 | 0.275 |
| Control group | 41 | 0.38 | 0.07 | EVNA | 1.099 | 0.275 | |||
| GIA | Patient group | 41 | 92.88 | 3.01 | EVA | 14.100 | 0.000 | 7.207 | 0.000** |
| Control group | 41 | 89.30 | 1.04 | EVNA | 7.207 | 0.000** | |||
NB. EVA = Equal variances assumed, EVNA = Equal variances not assumed.
*Significant at level 0.05, **Significant at level 0.01.
Multivariate tests.
| Multivariate Tests | ||||||
|---|---|---|---|---|---|---|
| Effect | Value | F | Hypothesis df | Error df | P-value | |
| Intercept | Pillai's Trace | 1.000 | 27951.104 | 6.000 | 75.000 | 0.000** |
| Wilks' Lambda | 0.000 | 27951.104 | 6.000 | 75.000 | 0.000** | |
| Hotelling's Trace | 2236.088 | 27951.104 | 6.000 | 75.000 | 0.000** | |
| Roy's Largest Root | 2236.088 | 27951.104 | 6.000 | 75.000 | 0.000** | |
| Group | Pillai's Trace | 0.594 | 18.315 | 6.000 | 75.000 | 0.000** |
| Wilks' Lambda | 0.406 | 18.315 | 6.000 | 75.000 | 0.000** | |
| Hotelling's Trace | 1.465 | 18.315 | 6.000 | 75.000 | 0.000** | |
| Roy's Largest Root | 1.465 | 18.315 | 6.000 | 75.000 | 0.000** | |
**Significant at level 0.01.
Tests of Between-Subjects Effects.
| Tests of Between-Subjects Effects | ||||||
|---|---|---|---|---|---|---|
| Source | Dependent Variable | Type III Sum of Squares | df | Mean Square | F | P-value |
| Group | GVA | 276.186 | 1 | 276.186 | 3.983 | 0.049* |
| GCH | 0.423 | 1 | 0.423 | 3.170 | 0.079 | |
| GAW | 1.012 | 1 | 1.012 | 8.845 | 0.004** | |
| Axial GD | 0.100 | 1 | 0.100 | 10.791 | 0.002** | |
| Coronal GD | 0.202 | 1 | 0.202 | 35.766 | 0.000** | |
| GD | 0.004 | 1 | 0.004 | 1.207 | 0.275 | |
| GIA | 263.775 | 1 | 263.775 | 51.942 | 0.000** | |
*Significant at level 0.05, **Significant at level 0.01.
Correlation between glenoid parameters and age in general and age in the two groups.
| Group | Total (n = 82) | Patient group (n = 41) | Control group (n = 41) | ||||
|---|---|---|---|---|---|---|---|
| Pearson Correlation | P-value | Pearson Correlation | P-value | Pearson Correlation | P-value | ||
| Glenoid parameters | GVA | 0.166 | 0.136 | 0.252 | 0.113 | 0.224 | 0.158 |
| GCH | 0.208 | 0.061 | 0.326 | 0.037* | −0.098 | 0.540 | |
| GAW | −0.117 | 0.296 | −0.018 | 0.913 | −0.052 | 0.745 | |
| GAD | −0.124 | 0.266 | 0.114 | 0.479 | −0.175 | 0.274 | |
| GCD | 0.251 | 0.023* | 0.243 | 0.126 | −0.034 | 0.835 | |
| GD | 0.081 | 0.467 | 0.283 | 0.073 | −0.152 | 0.342 | |
| GIA | 0.176 | 0.113 | −0.008 | 0.960 | 0.074 | 0.647 | |
*Significant at level 0.05.
Comparison of glenoid parameters by gender among patients with rotator cuff tears (patient group).
| Group | Group Statistics | Levene's Test for Equality of Variances | |||||||
|---|---|---|---|---|---|---|---|---|---|
| N | Mean | SD | Variances | F | P-value | t | P-value | ||
| GVA | Female | 11 | 3.24 | 4.41 | EVA | 6.559 | 0.014 | 0.477 | 0.636 |
| Male | 30 | 1.79 | 9.66 | EVNA | 0.656 | 0.516 | |||
| GCH | Female | 11 | 2.80 | 0.29 | EVA | 2.267 | 0.140 | −2.402 | 0.021* |
| Male | 30 | 3.14 | 0.43 | EVNA | −2.857 | 0.008** | |||
| GAW | Female | 11 | 2.76 | 0.20 | EVA | 2.684 | 0.109 | −2.952 | 0.005** |
| Male | 30 | 3.05 | 0.30 | EVNA | −3.554 | 0.001** | |||
| Axial GD | Female | 11 | 0.39 | 0.08 | EVA | 0.064 | 0.802 | 0.664 | 0.511 |
| Male | 30 | 0.37 | 0.09 | EVNA | 0.682 | 0.503 | |||
| Coronal GD | Female | 11 | 0.38 | 0.05 | EVA | 4.075 | 0.050 | −1.872 | 0.069 |
| Male | 30 | 0.43 | 0.09 | EVNA | −2.412 | 0.022* | |||
| GD | Female | 11 | 0.39 | 0.04 | EVA | 0.405 | 0.528 | −0.869 | 0.390 |
| Male | 30 | 0.40 | 0.06 | EVNA | −0.974 | 0.340 | |||
| GIA | Female | 11 | 93.71 | 1.70 | EVA | 1.801 | 0.187 | 1.060 | 0.296 |
| Male | 30 | 92.58 | 3.34 | EVNA | 1.410 | 0.168 | |||
*Significant at level 0.05, **Significant at level 0.01.
Comparison of glenoid parameters by gender among patients in the control group.
| Group | Group Statistics | Levene's Test for Equality of Variances | |||||||
|---|---|---|---|---|---|---|---|---|---|
| N | Mean | SD | Variances | F | P-value | T | P-value | ||
| GVA | Female | 16 | 4.60 | 3.69 | EVA | 10.049 | 0.003 | −0.788 | 0.435 |
| Male | 25 | 6.66 | 9.96 | EVNA | −0.936 | 0.356 | |||
| GCH | Female | 16 | 2.69 | 0.24 | EVA | 0.007 | 0.932 | −4.505 | 0.000** |
| Male | 25 | 3.04 | 0.25 | EVNA | −4.569 | 0.000** | |||
| GAW | Female | 16 | 2.91 | 0.33 | EVA | 0.233 | 0.632 | −4.850 | 0.000** |
| Male | 25 | 3.37 | 0.28 | EVNA | −4.664 | 0.000** | |||
| Axial GD | Female | 16 | 0.42 | 0.10 | EVA | 0.618 | 0.437 | −1.248 | 0.219 |
| Male | 25 | 0.46 | 0.11 | EVNA | −1.270 | 0.213 | |||
| Coronal GD | Female | 16 | 0.29 | 0.06 | EVA | 0.230 | 0.634 | −2.379 | 0.022* |
| Male | 25 | 0.34 | 0.06 | EVNA | −2.378 | 0.024* | |||
| GD | Female | 16 | 0.35 | 0.06 | EVA | 0.342 | 0.562 | −2.176 | 0.036* |
| Male | 25 | 0.40 | 0.07 | EVNA | −2.180 | 0.037* | |||
| GIA | Female | 16 | 89.51 | 0.77 | EVA | 1.442 | 0.237 | 1.057 | 0.297 |
| Male | 25 | 89.16 | 1.18 | EVNA | 1.157 | 0.254 | |||
*Significant at level 0.05, **Significant at level 0.01.
Comparison of glenoid parameters between females with rotator cuff tears and females in the control group.
| Parameters | Group | Group Statistics | Levene's Test for Equality of Variances | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N | Mean | SD | Variances | F | P-value | t | P-value | ||
| GVA | Patient group | 11 | 3.24 | 4.41 | EVA | 0.511 | 0.481 | −0.866 | 0.395 |
| Control group | 16 | 4.60 | 3.69 | EVNA | −0.837 | 0.413 | |||
| GCH | Patient group | 11 | 2.80 | 0.29 | EVA | 1.003 | 0.326 | 1.100 | 0.282 |
| Control group | 16 | 2.69 | 0.24 | EVNA | 1.055 | 0.305 | |||
| GAW | Patient group | 11 | 2.76 | 0.20 | EVA | 3.416 | 0.076 | −1.328 | 0.196 |
| Control group | 16 | 2.91 | 0.33 | EVNA | −1.455 | 0.158 | |||
| GAD | Patient group | 11 | 0.39 | 0.08 | EVA | 0.262 | 0.613 | −0.805 | 0.429 |
| Control group | 16 | 0.42 | 0.10 | EVNA | −0.835 | 0.412 | |||
| GCD | Patient group | 11 | 0.38 | 0.05 | EVA | 1.922 | 0.178 | 3.957 | 0.001** |
| Control group | 16 | 0.29 | 0.06 | EVNA | 4.171 | 0.000** | |||
| GD | Patient group | 11 | 0.39 | 0.04 | EVA | 0.903 | 0.351 | 1.372 | 0.182 |
| Control group | 16 | 0.35 | 0.06 | EVNA | 1.478 | 0.152 | |||
| GIA | Patient group | 11 | 93.71 | 1.70 | EVA | 5.992 | 0.022 | 8.709 | 0.000** |
| Control group | 16 | 89.51 | 0.77 | EVNA | 7.662 | 0.000** | |||
**Significant at level 0.01.
Comparison of glenoid parameters between males with rotator cuff tears and males in the control group.
| Parameters | Group | Group Statistics | Levene's Test for Equality of Variances | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N | Mean | SD | Variances | F | P-value | T | P-value | ||
| GVA | Patient group | 30 | 1.79 | 9.66 | EVA | 0.000 | 0.998 | −1.832 | 0.073 |
| Control group | 25 | 6.66 | 9.96 | EVNA | −1.827 | 0.074 | |||
| GCH | Patient group | 30 | 3.14 | 0.43 | EVA | 9.507 | 0.003 | 0.989 | 0.327 |
| Control group | 25 | 3.04 | 0.25 | EVNA | 1.036 | 0.306 | |||
| GAW | Patient group | 30 | 3.05 | 0.30 | EVA | 0.003 | 0.957 | −4.197 | 0.000** |
| Control group | 25 | 3.37 | 0.28 | EVNA | −4.222 | 0.000** | |||
| GAD | Patient group | 30 | 0.37 | 0.09 | EVA | 2.153 | 0.148 | −3.476 | 0.001** |
| Control group | 25 | 0.46 | 0.11 | EVNA | −3.409 | 0.001** | |||
| GCD | Patient group | 30 | 0.43 | 0.09 | EVA | 2.964 | 0.091 | 4.472 | 0.000** |
| Control group | 25 | 0.34 | 0.06 | EVNA | 4.596 | 0.000** | |||
| GD | Patient group | 30 | 0.40 | 0.06 | EVA | 1.904 | 0.173 | 0.080 | 0.937 |
| Control group | 25 | 0.40 | 0.07 | EVNA | 0.079 | 0.938 | |||
| GIA | Patient group | 30 | 92.58 | 3.34 | EVA | 8.367 | 0.006 | 4.870 | 0.000** |
| Control group | 25 | 89.16 | 1.18 | EVNA | 5.234 | 0.000** | |||
**Significant at level 0.01.
Multivariate analysis.
| Multivariate Tests | ||||||
|---|---|---|---|---|---|---|
| Effect | Value | F | Hypothesis df | Error df | P-value | |
| Intercept | Pillai's Trace | 0.994 | 1987.799 | 6.000 | 74.000 | 0.000** |
| Wilks' Lambda | 0.006 | 1987.799 | 6.000 | 74.000 | 0.000** | |
| Hotelling's Trace | 161.173 | 1987.799 | 6.000 | 74.000 | 0.000** | |
| Roy's Largest Root | 161.173 | 1987.799 | 6.000 | 74.000 | 0.000** | |
| Group | Pillai's Trace | 0.593 | 17.933 | 6.000 | 74.000 | 0.000** |
| Wilks' Lambda | 0.407 | 17.933 | 6.000 | 74.000 | 0.000** | |
| Hotelling's Trace | 1.454 | 17.933 | 6.000 | 74.000 | 0.000** | |
| Roy's Largest Root | 1.454 | 17.933 | 6.000 | 74.000 | 0.000** | |
| Sexe | Pillai's Trace | 0.415 | 8.741 | 6.000 | 74.000 | 0.000** |
| Wilks' Lambda | 0.585 | 8.741 | 6.000 | 74.000 | 0.000** | |
| Hotelling's Trace | 0.709 | 8.741 | 6.000 | 74.000 | 0.000** | |
| Roy's Largest Root | 0.709 | 8.741 | 6.000 | 74.000 | 0.000** | |
**Significant at level 0.01.
Tests of Between-Subjects Effects.
| Tests of Between-Subjects Effects | ||||||
|---|---|---|---|---|---|---|
| Source | Dependent Variable | Type III Sum of Squares | Df | Mean Square | F | P-value |
| Group | GVA | 280.095 | 1 | 280.095 | 3.991 | 0.049* |
| GCH | 0.207 | 1 | 0.207 | 1.917 | 0.170 | |
| GAW | 1.457 | 1 | 1.457 | 17.594 | 0.000** | |
| Axial GD | 0.103 | 1 | 0.103 | 11.042 | 0.001** | |
| Coronal GD | 0.175 | 1 | 0.175 | 33.963 | 0.000** | |
| GD | 0.002 | 1 | 0.002 | 0.673 | 0.414 | |
| GIA | 271.840 | 1 | 271.840 | 54.024 | 0.000** | |
*Significant at level 0.05, **Significant at level 0.01.